Fabrication of PLA-Based Nanoneedle Patches Loaded with Transcutol-Modified Chitosan Nanoparticles for the Transdermal Delivery of Levofloxacin

• Published in: Molecules (Basel, Switzerland) Vol. 29; no. 18; p. 4289
• Main Authors: Samiotaki, Christina, Koumentakou, Ioanna, Christodoulou, Evi, Bikiaris, Nikolaos D, Vlachou, Marilena, Karavas, Evangelos, Tourlouki, Konstantina, Kehagias, Nikolaos, Barmpalexis, Panagiotis
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 10.09.2024; MDPI
• Subjects: Administration, Cutaneous; Animals; Anti-Bacterial Agents - administration & dosage; Anti-Bacterial Agents - chemistry; Chitosan - chemistry; Drug Carriers - chemistry; Drug Delivery Systems; Drug Liberation; drug release; Ethylene; Levofloxacin; Levofloxacin - administration & dosage; Levofloxacin - chemistry; nanoencapsulation; nanoneedles; Nanoparticles; Nanoparticles - chemistry; Particle Size; Permeability; Pharmaceuticals; poly(lactic acid) blends; Polyesters - chemistry; Polymers; Ratios; Skin; Skin - metabolism; Skin Absorption; Spectrum analysis; Toxicity; transdermal delivery; Transdermal medication; Transdermal Patch; Vibration; Greece; Japan; Germany; nanoneedles; nanoencapsulation; drug release; levofloxacin; transdermal delivery; poly(lactic acid) blends
• ISSN: 1420-3049; 1420-3049
• DOI: 10.3390/molecules29184289

Current transdermal drug delivery technologies, like patches and ointments, effectively deliver low molecular weight drugs through the skin. However, delivering larger, hydrophilic drugs and macromolecules remains a challenge. In the present study, we developed novel transdermal nanoneedle patches containing levofloxacin-loaded modified chitosan nanoparticles. Chitosan was chemically modified with transcutol in three ratios (1/1, 1/2, 1/3, / ), and the optimum ratio was used for nanoparticle fabrication via the ionic gelation method. The successful modification was confirmed using ATR-FTIR spectroscopy, while DLS results revealed that only the 1/3 ratio afforded suitably sized particles of 220 nm. After drug encapsulation, the particle size increased to 435 nm, and the final formulations were examined via XRD and an in vitro dissolution test, which suggested that the nanoparticles reach 60% release in a monophasic pattern at 380 h. We then prepared transdermal patches with pyramidal geometry nanoneedles using different poly(lactic acid)/poly(ethylene adipate) (PLA/PEAd) polymer blends of varying ratios, which were characterized in terms of morphology and mechanical compressive strength. The 90/10 blend exhibited the best mechanical properties and was selected for further testing. Ex vivo permeation studies proved that the nanoneedle patches containing drug-loaded nanoparticles achieved the highest levofloxacin permeation (88.1%).